BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34818661)

  • 1. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
    Karki NR; Arfa AS; Savage N; Kutlar A
    Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five biopsies, one diagnosis: challenges in idiopathic multicentric Castleman disease.
    Semenchuk J; Merchant A; Sakhdari A; Kukreti V
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.
    Smedile A; Capuano F; Fraticelli S; Lucioni M; La Fianza A
    J Radiol Case Rep; 2019 Mar; 13(3):28-36. PubMed ID: 31565175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab.
    Plano F; Mancuso S; Camarda GM; Butera MG; Sucato G; Alecci G; Florena AM; Perrone S; Siragusa SM
    Chemotherapy; 2024; 69(1):35-39. PubMed ID: 37634492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castleman disease: a rare case in a young woman.
    Paparella MT; Popolizio T; Grasso D; Serricchio EA; Guglielmi G
    Acta Biomed; 2023 Mar; 94(S1):e2023058. PubMed ID: 36883699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Castleman disease and TAFRO syndrome.
    Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
    Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal Castleman disease in pediatrics: case report.
    Baserga M; Rosin M; Schoen M; Young G
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
    Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report.
    Kosmidis CS; Mystakidou CM; Koimtzis G; Papadopoulou E; Theodorou V; Katsios NI; Georgakoudi E; Sevva C; Charalampous I; Varsamis N; Koulouris C; Michael C; Papadopoulos K; Anthimidis G; Baka S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomeruloid hemangioma associated with TAFRO syndrome.
    Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
    Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.
    Horna P; King RL; Jevremovic D; Fajgenbaum DC; Dispenzieri A
    Haematologica; 2023 Jan; 108(1):207-218. PubMed ID: 35484648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease.
    Chrysochoou S; Kreft A; Schneider E
    Case Rep Hematol; 2022; 2022():1840589. PubMed ID: 35399163
    [No Abstract]   [Full Text] [Related]  

  • 19. Castleman disease of the neck: A case report.
    Pasha H; Siddiqui MI; Wasif M
    J Pak Med Assoc; 2020 Feb; 70(2):354-356. PubMed ID: 32063646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman disease presenting as a chylous pleural effusion.
    Epstein D; Zohar Y; Ovadya D; Ammouri H; Kremer R; Lavi N; Tzoran I; Andrawas ER; Klein E; Miller A
    Pathol Res Pract; 2020 Nov; 216(11):153209. PubMed ID: 32950896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.